{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:candesartan",
  "owner": "cardio",
  "kind": "drug",
  "slug": "candesartan",
  "name": "Candesartan",
  "aliases": [
    "Atacand",
    "Candesartan cilexetil"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "Candesartan is an ARB (angiotensin II receptor blocker), a medicine taken by mouth. The US label read, for ATACAND tablets (candesartan cilexetil), lists two uses: treating high blood pressure in adults and in children 1 to under 17 years of age, and treating heart failure (NYHA class II-IV), where the label says it reduces cardiovascular death and heart failure hospitalization. Atacand is the brand name on the label read.",
  "summary_technical": "RxNorm ingredient 214354; UNII R85M2X0D68. The label names the substance as candesartan cilexetil, a prodrug that the label says is hydrolyzed to candesartan, so UNII R85M2X0D68 is the UNII of the cilexetil ester and is a broad match. MeSH has no descriptor for candesartan; C077793 is the MeSH supplementary concept record for candesartan cilexetil, also a broad match. Class: Angiotensin 2 Receptor Blocker (FDA established pharmacologic class, RxClass). The label read is the ANI Pharmaceuticals, Inc. label for ATACAND (candesartan cilexetil) tablets, application NDA020838, effective 2025-12-22 in openFDA; Drugs@FDA lists the application's sponsor as ANI PHARMS. Generic candesartan labels and the ATACAND HCT combination label were not read. This page records label indications and the class only: no trial result and no dose is given.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-09",
  "last_evidence_check": "2026-11-09",
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "rxnorm",
      "value": "214354",
      "normalized_value": "214354",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    },
    {
      "scheme": "unii",
      "value": "R85M2X0D68",
      "normalized_value": "R85M2X0D68",
      "match": "broad",
      "version": null,
      "label": null,
      "from_source": false
    },
    {
      "scheme": "mesh",
      "value": "C077793",
      "normalized_value": "C077793",
      "match": "broad",
      "version": "read 2026-11-09",
      "label": null,
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "system": [
        "heart",
        "blood-vessels"
      ],
      "condition-area": [
        "hypertension",
        "heart-failure"
      ]
    }
  },
  "payload": {
    "level": "substance",
    "mechanism": null
  },
  "content_digest": "2731a12b2f9c4c04b600b2872d010a8589c82f9aeffb9935a0b52ba638fba0a2",
  "review": {
    "content_digest": "2731a12b2f9c4c04b600b2872d010a8589c82f9aeffb9935a0b52ba638fba0a2",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [
    {
      "release_id": "a25293eeae6350fb",
      "id": "cardio:claim-fda-candesartan-label-indications-children",
      "owner": "cardio",
      "subject_entity_id": "cardio:candesartan",
      "category": "descriptive",
      "statement": "The US label of ATACAND (candesartan cilexetil) tablets, in the ANI Pharmaceuticals, Inc. version dated 2025-12-22 in openFDA, lists the medicine for the treatment of hypertension, to lower blood pressure, in children 1 to under 17 years of age.",
      "context": {
        "id": "cardio:ctx-fda-candesartan-label-us-children",
        "label": "Children for whom the US label of candesartan (Atacand) lists hypertension as an indication: children 1 to under 17 years of age",
        "recipient": "child",
        "population": "Children with hypertension, as the indications section of the label describes them. The same label sentence also names adults, who are recorded in a separate context.",
        "care_setting": "Prescription medicine, as described in the US label",
        "geography": "United States (label of the US Food and Drug Administration)",
        "life_stage_note": "Label wording: children 1 to under 17 years of age",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (label statement)",
        "eligibility": {
          "inclusion": [
            "Children with hypertension (children 1 to under 17 years of age)"
          ],
          "exclusion": []
        }
      },
      "evidence_stage": "not_applicable",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "This claim records what the label says the medicine is indicated for in children. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label may list other indications that were not recorded. Contraindications, doses, interactions and warnings were not read, and the label has a boxed warning section whose content was not read or recorded. Labels change, and openFDA also lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.",
      "editorial_state": "draft",
      "checked_at": "2026-11-09",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], 1 INDICATIONS AND USAGE",
          "applicability_note": "The label sentence that names children in the hypertension indication, quoted in the research quote table.",
          "snapshot": {
            "id": "cardio:openfda-label-atacand-2026-11-09",
            "retrieved_at": "2026-11-09T13:19:06Z",
            "content_hash": "6e366d099c851afcac0f711669c077763a34505dc03331674c97f4d2f3593f5a",
            "source_effective_date": "2025-12-22",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-atacand",
            "source_type": "regulator",
            "title": "openFDA drug label record for ATACAND (candesartan cilexetil) tablets, ANI Pharmaceuticals, Inc. label: indications and substance identifiers",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%2294a59260-d2b6-464a-b5b9-bbc599e57e10%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 94a59260-d2b6-464a-b5b9-bbc599e57e10 (manufacturer ANI Pharmaceuticals, Inc., application NDA020838), returned on 2026-11-09. The label text is dated 2025-12-22 (effective_time). Other openFDA records of candesartan labels from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/wb22-openfda-label-candesartan.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "context",
          "locator": "results[0].effective_time",
          "applicability_note": "Effective date of the label text read, 20251222.",
          "snapshot": {
            "id": "cardio:openfda-label-atacand-2026-11-09",
            "retrieved_at": "2026-11-09T13:19:06Z",
            "content_hash": "6e366d099c851afcac0f711669c077763a34505dc03331674c97f4d2f3593f5a",
            "source_effective_date": "2025-12-22",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-atacand",
            "source_type": "regulator",
            "title": "openFDA drug label record for ATACAND (candesartan cilexetil) tablets, ANI Pharmaceuticals, Inc. label: indications and substance identifiers",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%2294a59260-d2b6-464a-b5b9-bbc599e57e10%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 94a59260-d2b6-464a-b5b9-bbc599e57e10 (manufacturer ANI Pharmaceuticals, Inc., application NDA020838), returned on 2026-11-09. The label text is dated 2025-12-22 (effective_time). Other openFDA records of candesartan labels from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/wb22-openfda-label-candesartan.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        }
      ],
      "review": {
        "content_digest": "645e5ebaa39f476928c933414147d51807e4aa24f735fbd3b250caff930cacd7",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-fda-candesartan-label-indications-children.json"
    },
    {
      "release_id": "a25293eeae6350fb",
      "id": "cardio:claim-fda-candesartan-label-indications",
      "owner": "cardio",
      "subject_entity_id": "cardio:candesartan",
      "category": "descriptive",
      "statement": "The US label of ATACAND (candesartan cilexetil) tablets, in the ANI Pharmaceuticals, Inc. version dated 2025-12-22 in openFDA, lists the medicine for the treatment of hypertension in adults, to lower blood pressure (the same label sentence also names children 1 to under 17 years of age, recorded separately); and for the treatment of heart failure (NYHA class II-IV), with the label stating that the medicine reduces cardiovascular death and heart failure hospitalization.",
      "context": {
        "id": "cardio:ctx-fda-candesartan-label-us",
        "label": "Patients for whom the US label of candesartan (Atacand) lists an indication: adult hypertension, NYHA class II-IV heart failure",
        "recipient": "unknown",
        "population": "Patients described in the indications section of the label. The hypertension indication names adults (and, separately, children 1 to under 17 years of age); the heart failure indication does not state an age range.",
        "care_setting": "Prescription medicine, as described in the US label",
        "geography": "United States (label of the US Food and Drug Administration)",
        "life_stage_note": "Adults for hypertension, as the passage read states; not stated for heart failure",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (label statement)",
        "eligibility": {
          "inclusion": [
            "Adult patients with hypertension",
            "Patients with heart failure (NYHA class II-IV)"
          ],
          "exclusion": []
        }
      },
      "evidence_stage": "not_applicable",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "This claim records what the label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label may list other indications that were not recorded. Contraindications, doses, interactions and warnings were not read, and the label has a boxed warning section whose content was not read or recorded. Labels change, and openFDA also lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.",
      "editorial_state": "draft",
      "checked_at": "2026-11-09",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], 1 INDICATIONS AND USAGE",
          "applicability_note": "The label sentences that give the indications named in the statement, each quoted in the research quote table.",
          "snapshot": {
            "id": "cardio:openfda-label-atacand-2026-11-09",
            "retrieved_at": "2026-11-09T13:19:06Z",
            "content_hash": "6e366d099c851afcac0f711669c077763a34505dc03331674c97f4d2f3593f5a",
            "source_effective_date": "2025-12-22",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-atacand",
            "source_type": "regulator",
            "title": "openFDA drug label record for ATACAND (candesartan cilexetil) tablets, ANI Pharmaceuticals, Inc. label: indications and substance identifiers",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%2294a59260-d2b6-464a-b5b9-bbc599e57e10%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 94a59260-d2b6-464a-b5b9-bbc599e57e10 (manufacturer ANI Pharmaceuticals, Inc., application NDA020838), returned on 2026-11-09. The label text is dated 2025-12-22 (effective_time). Other openFDA records of candesartan labels from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/wb22-openfda-label-candesartan.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "context",
          "locator": "results[0].effective_time",
          "applicability_note": "Effective date of the label text read, 20251222.",
          "snapshot": {
            "id": "cardio:openfda-label-atacand-2026-11-09",
            "retrieved_at": "2026-11-09T13:19:06Z",
            "content_hash": "6e366d099c851afcac0f711669c077763a34505dc03331674c97f4d2f3593f5a",
            "source_effective_date": "2025-12-22",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-atacand",
            "source_type": "regulator",
            "title": "openFDA drug label record for ATACAND (candesartan cilexetil) tablets, ANI Pharmaceuticals, Inc. label: indications and substance identifiers",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%2294a59260-d2b6-464a-b5b9-bbc599e57e10%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 94a59260-d2b6-464a-b5b9-bbc599e57e10 (manufacturer ANI Pharmaceuticals, Inc., application NDA020838), returned on 2026-11-09. The label text is dated 2025-12-22 (effective_time). Other openFDA records of candesartan labels from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/wb22-openfda-label-candesartan.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "context",
          "locator": "results[0].products[0].brand_name",
          "applicability_note": "Drugs@FDA product listing for application NDA020838, which confirms the product the label belongs to.",
          "snapshot": {
            "id": "cardio:drugsfda-nda020838-2026-11-09",
            "retrieved_at": "2026-11-09T13:20:36Z",
            "content_hash": "ec1683f25cf3821591331aea65021120395a52d28829ac5fc903c50d651cbef8",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:drugsfda-nda020838",
            "source_type": "regulator",
            "title": "openFDA Drugs@FDA record for application NDA020838 (ATACAND, sponsor ANI PHARMS): product and sponsor",
            "canonical_url": "https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA020838%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA, Drugs@FDA)",
            "edition": "The openFDA Drugs@FDA record for application NDA020838, returned on 2026-11-09. It lists the sponsor and the products of the application; only the first product listing is quoted.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short values are quoted. The raw record is committed at research/snapshots/wb22-drugsfda-candesartan.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        }
      ],
      "review": {
        "content_digest": "42563b5d2967c0898978ab4ddd4dd977bf20ee1d7b387de0f1dc7613c3de86f4",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-fda-candesartan-label-indications.json"
    }
  ],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "subtype_of",
        "label": "Candesartan is an ARB (FDA established pharmacologic class in RxClass)",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:angiotensin-receptor-blockers-arbs",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-214354-2026-11-09",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "FDA label lists hypertension as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "core:hypertension",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-candesartan-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "FDA label lists NYHA class II to IV heart failure as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "cardio:heart-failure",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-candesartan-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "part_of",
        "label": "Files under this front",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:front-medicines",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": [
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01135212",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01135212-2012-08-24",
          "locator": "protocolSection.armsInterventionsModule.interventions[2].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01434134",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01434134-2014-10-22",
          "locator": "protocolSection.armsInterventionsModule.interventions[2].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01629225",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01629225-2014-11-18",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01984164",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01984164-2021-02-21",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct02332824",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct02332824-2018-08-13",
          "locator": "protocolSection.armsInterventionsModule.interventions[2].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct02774460",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct02774460-2021-09-01",
          "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct03847506",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct03847506-2022-05-10",
          "locator": "protocolSection.armsInterventionsModule.interventions[2].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct05321875",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct05321875-2024-11-07",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda020838",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda020838-2020-06-24",
          "locator": "products[0].active_ingredients[0].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda021093",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda021093-2020-08-20",
          "locator": "products[0].active_ingredients[0].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      }
    ]
  },
  "page_path": "drugs/candesartan/",
  "context_path": "api/v1/context/cardio--candesartan.md"
}
